Carlo Di Mario
Eckhart Fleck
REFERENCE: Hot Line II, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, AustriaCARLO DI MARIO, Royal Brompton Hospital, LondonCOMMENT: ECKART FLECK, Deutsches Herzzentrum BerlinThe CARESS study from Milan and London has shown that for younger, high-risk patients experiencing a myocardial infarction there can be a clear benefit from performing angioplasty as soon as it is available after using lytics with anti-platelet therapy in situations where primary angioplasty is not available. This answers a huge un-met need of what is best to do for patients who are admitted initially to a centre where primary percutaneous intervention is not an immediate option. At the cardiology congress in ViennaCarlo Di Mariotold Peter Goodwin that patients at lower risk of bleeding who can proceed to angioplasty should do so.Eckhart Fleckadded his comments about following lytic therapy with angioplasty.
Related Episodes
Bivalirudin For Angioplasty: Expensive Heparin?
Tony Gershlick Tony Gershlick, University of Leicester Adnan Kastrati, Deutsches Herzzentrum, Munich Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing deat
Remove Thrombus Before Primary Angioplasty!
Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,
Routine Angioplasty Recommended After Thrombolysis
Warren Cantor Tony Gershlick REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction Warren Cantor, University of Toronto COMMENT: Tony Gershlick, Leicester